Latest News about IGC
Recent news which mentions IGC
From Benzinga
From Benzinga
IGC Q3 2023 Revenue Grows 133% YoY, What About Net Loss?
February 15, 2023
Tickers
IGC
From Benzinga
IGC Expanding Clinical Trials Of THC Based Drug Following Approval From Health Canada
January 04, 2023
Tickers
IGC
From Benzinga
IGC Starts Phase 2 Clinical Trials Of THC Based Drug Candidate For The Treatment Of Agitation In Dementia From Alzheimer's Disease
December 01, 2022
Tickers
IGC
From Benzinga
IGC Q2 2023 Revenue Grows 261%, THC Based Drug For Alzheimer's Entering Phase 2 Trials
November 02, 2022
Tickers
IGC
From Benzinga
From InvestorPlace
IGC Announces Issuance Of Second Patent For The Treatment Of Alzheimer's Using THC
September 21, 2022
Tickers
IGC
From Benzinga
91 Biggest Movers From Friday
June 13, 2022
From Benzinga
44 Stocks Moving In Friday's Mid-Day Session
June 10, 2022
From Benzinga
69 Biggest Movers From Yesterday
June 10, 2022
From Benzinga
36 Stocks Moving In Thursday's Mid-Day Session
June 09, 2022
From Benzinga
IGC Receives U.S. Patent For Method And Composition For Treating Seizure Disorders, Utilizing CBD
June 09, 2022
Tickers
IGC
From Benzinga
From InvestorPlace
18 Stocks Moving in Thursday's Pre-Market Session
June 09, 2022
From Benzinga
83 Biggest Movers From Yesterday
June 09, 2022
From Benzinga
From InvestorPlace
64 Biggest Movers From Friday
March 28, 2022
From Benzinga
36 Stocks Moving In Friday's Mid-Day Session
March 25, 2022
From Benzinga
34 Stocks Moving in Friday's Pre-Market Session
March 25, 2022
From Benzinga
Cannabis Stocks That Moved On News That Federal Cannabis Legalization Bill Heads To House For Vote Next Week
March 24, 2022
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.